Pågående emisjoner, børsnoteringer o.l.

Solon Eiendom ASA – Subsequent offering

(16.05.2018) DNB Markets is acting as a Manager for Solon Eiendom ASA (“Solon Eiendom” or the “Company”).
Read more and download prospectus

Vistin Pharma ASA – Subsequent offering

(14.05.2018) DNB Markets is acting as a Manager in relation to the subsequent offering in Vistin Pharma ASA (“Vistin Pharma” or the “Company”).
Read more, download prospectus and subscription form

Offer document and acceptance form regarding Alexion Pharma Nordics Holding AB’s recommended public cash offer to shareholders in Wilson Therapeutics AB made public

(24.04.2018) DNB Markets is acting as Nordic financial adviser and settlement agent in connection with Alexion Pharma Nordics Holding AB recommended public cash offer to acquire all outstanding shares in Wilson Therapeutics AB at a price of SEK 232 per share.
Read more and download prospectus

Kontakt DNB Markets
Investment Banking Division
Telefon: 23 26 81 01
» Send e-post 

Aksjehandel/-analyse
Telefon: 915 08940
» Send e-post

Vilkår og avtaler

Pågående emisjoner

Arkiv emisjoner